Combination of terbium-161 with somatostatin receptor antagonists—a potential paradigm shift for the treatment of neuroendocrine neoplasms

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1619-7089
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Combination of terbium-161 with somatostatin receptor antagonists—a potential paradigm shift for the treatment of neuroendocrine neoplasms ; day:8 ; month:10 ; year:2021 ; pages:1-14
European journal of nuclear medicine and molecular imaging ; (8.10.2021), 1-14

Urheber
Borgna, Francesca
Haller, Stephanie
Rodriguez, Josep M. Monné
Ginj, Mihaela
Grundler, Pascal V.
Zeevaart, Jan Rijn
Köster, Ulli
Schibli, Roger
Van der Meulen, Nicholas P.
Müller, Cristina
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1007/s00259-021-05564-0
URN
urn:nbn:de:101:1-2021122508145225526248
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:27 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Borgna, Francesca
  • Haller, Stephanie
  • Rodriguez, Josep M. Monné
  • Ginj, Mihaela
  • Grundler, Pascal V.
  • Zeevaart, Jan Rijn
  • Köster, Ulli
  • Schibli, Roger
  • Van der Meulen, Nicholas P.
  • Müller, Cristina
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Challenges in High-grade Neuroendocrine Neoplasms and Mixed Neuroendocrine/Non-neuroendocrine Neoplasms

Challenges in High-grade Neuroendocrine Neoplasms and Mixed Neuroendocrine/Non-neuroendocrine Neoplasms

Different somatostatin and CXCR4 chemokine receptor expression in gastroenteropancreatic neuroendocrine neoplasms depending on their origin

Different somatostatin and CXCR4 chemokine receptor expression in gastroenteropancreatic neuroendocrine neoplasms depending on their origin

Neuroendocrine neoplasms: radiologic-clinical correlation

Neuroendocrine neoplasms: radiologic-clinical correlation

P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms

P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms

Some Considerations on Laryngeal Neuroendocrine Neoplasms

Some Considerations on Laryngeal Neuroendocrine Neoplasms

Imaging presentation of pancreatic neuroendocrine neoplasms

Imaging presentation of pancreatic neuroendocrine neoplasms

Management of Functional Pancreatic Neuroendocrine Neoplasms

Management of Functional Pancreatic Neuroendocrine Neoplasms

New Developments in Gastric Neuroendocrine Neoplasms

New Developments in Gastric Neuroendocrine Neoplasms

New Directions in Imaging Neuroendocrine Neoplasms

New Directions in Imaging Neuroendocrine Neoplasms

Update Regarding Imaging of Neuroendocrine Neoplasms

Update Regarding Imaging of Neuroendocrine Neoplasms

Long-term surgical outcomes of gastric neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasms

Long-term surgical outcomes of gastric neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasms

Mixed neuroendocrine–non-neuroendocrine neoplasms of the gallbladder: a case report

Mixed neuroendocrine–non-neuroendocrine neoplasms of the gallbladder: a case report

Verbundene Objekte